12
Histol Histopathol (2000) 15: 131 -1 42 http://www.ehu.es/histol-histopathol Invited Revie W Histology and Histo pathology Cellular and Molecular Biology The female prostate and prostate-specific antigen. lmmunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female M. Zavia&iEl and R.J. Ablin 2 'Department of Pathology, Comenius University School of Medicine, Bratislava, Slovakia and 21nnapharma. Inc., Suffern, NY, USA Summary. Prostate-specific antigen (PSA) is currently the most frequently used marker for the identification of normal and pathologically altered prostatic tissue in the male and female. Immunohistochemically PSA is expressed in the highly specialized apically-superficial layer of female and male secretory cells of the prostate gland, as well as in uroepithelial cells at other sites of the urogenital tract of both sexes. Unique active moieties of cells of the female and the male prostate gland and in other parts of the urogenital tract are indicative of secretory and protective function of specialized prostatic and uroepithelial cells with strong immunological properties given by the presence of PSA. In clinical practice, PSA is a valuable marker for the diagnosis and monitoring of diseases of the male and the female prostate, especially carcinoma. In the female, similarly as in the male, the prostate (Skene's gland) is the principal source of PSA. The value of PSA in women increases in the pathological female prostate, e.g., carcinoma. Nevertheless, the total amount of PSA in the female is the sum of normal or pathological female prostate and non-prostatic female tissues production, e.g., of diseased female breast tissue. The expression of an antigen specific for the male prostate, i.e., PSA in female Skene's glands and ducts, and structural and functional parameters and diseases similar to that of the male prostate, have provided convincing evidence of the existence of a prostate in women and definitive preference of the term "prostate" over that of Skene's glands and ducts. The use of the term Skene's glands incorrectly implies that some other structure rather than prostate is involved, promoting the vestigial position of this female organ. Offprint requests to: Professor Milan ZaviaEE, MD, DSc., Department of Pathology, Cornenius University School of Medicine, Sasinkova 4, 81 1 08 Bratislava, Slovakia. Fax: 00421 -7-59357592 Key words: Prostate- specific antigen (PSA), Female prostate, Skene's gland, Male prostate, Immunohisto- chemistry, Serology, Female PSA implications, Male PSA implications, Terminology Introduction Reinier de Graaf (1641-1673), a Dutch physiologist and histologist, was the first to describe the female prostate and to assign it this term (de Graaf, 1672). One year before his death, de Graaf (1672) described in his work "De mulierum organis generationi inservientibus . . . ." exactly, and perfectly for his time, the structure of the female prostate as being formed by glands and ducts located around the female urethra. De Graaf was also the first who attempted to formulate the function of the female prostate on writing: "The function of the prostate (corpus glandulosum) is to generate a pituitoserous juice which makes women more libidinous with its pungency and saltiness and lubricates their sexual parts in agreeable fashion during coitus" (Jocelyn and Setchell, 1972). Although de Graaf's notion of homology of the female paraurethral glands and ducts as the female prostate with the male prostate was essentially but an intuitive idea, he is doubtless the discoverer of the female prostate and should be accepted and acknowledged as such. Some 200 years after de Graaf, the American gynecologist, Alexander J.C. Skene (1838-1900), redescribed the female prostate as being comprised of two main paraurethral ducts that bear his name - Skene's glands - opening on both sides of the urethral orifice (Skene, 1880). Following Skene's description, the origin, and even the presence and function of these (para)urethral ducts and glands, became the subject of considerable debate. This contributed to a general

Invited Re vie W female prosta… · The female prostate and prostate-specific antigen. lmmunohistochemical localization, implications of this prostate marker in women and reasons

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

  • Histol Histopathol (2000) 15: 131 -1 42

    http://www.ehu.es/histol-histopathol

    Invited Re vie W

    Histology and Histo pathology Cellular and Molecular Biology

    The female prostate and prostate-specific antigen. lmmunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female M. Zavia&iEl and R.J. Ablin2

    'Department of Pathology, Comenius University School of Medicine, Bratislava, Slovakia and 21nnapharma. Inc., Suffern, NY, USA

    Summary. Prostate-specific antigen (PSA) is currently the most frequently used marker for the identification of normal and pathologically altered prostatic tissue in the male and female. Immunohistochemically PSA is expressed in the highly specialized apically-superficial layer of female and male secretory cells of the prostate gland, as well as in uroepithelial cells at other sites of the urogenital tract of both sexes. Unique active moieties of cells of the female and the male prostate gland and in other parts of the urogenital tract are indicative of secretory and protective function of specialized prostatic and uroepithelial cells with strong immunological properties given by the presence of PSA. In clinical practice, PSA is a valuable marker for the diagnosis and monitoring of diseases of the male and the female prostate, especially carcinoma. In the female, similarly as in the male, the prostate (Skene's gland) is the principal source of PSA. The value of PSA in women increases in the pathological female prostate, e.g., carcinoma. Nevertheless, the total amount of PSA in the female is the sum of normal or pathological female prostate and non-prostatic female tissues production, e.g., of diseased female breast tissue. The expression of an antigen specific for the male prostate, i.e., PSA in female Skene's glands and ducts, and structural and functional parameters and diseases similar to that of the male prostate, have provided convincing evidence of the existence of a prostate in women and definitive preference of the term "prostate" over that of Skene's glands and ducts. The use of the term Skene's glands incorrectly implies that some other structure rather than prostate is involved, promoting the vestigial position of this female organ.

    Offprint requests to: Professor Milan ZaviaEE, MD, DSc., Department of Pathology, Cornenius University School of Medicine, Sasinkova 4, 81 1 08 Bratislava, Slovakia. Fax: 00421 -7-59357592

    Key words: Prostate-specific antigen (PSA), Female prostate, Skene's gland, Male prostate, Immunohisto- chemistry, Serology, Female PSA implications, Male PSA implications, Terminology

    Introduction

    Reinier de Graaf (1641-1673), a Dutch physiologist and histologist, was the first to describe the female prostate and to assign it this term (de Graaf, 1672). One year before his death, de Graaf (1672) described in his work "De mulierum organis generationi inservientibus . . . ." exactly, and perfectly for his time, the structure of the female prostate as being formed by glands and ducts located around the female urethra. De Graaf was also the first who attempted to formulate the function of the female prostate on writing: "The function of the prostate (corpus glandulosum) is to generate a pituitoserous juice which makes women more libidinous with its pungency and saltiness and lubricates their sexual parts in agreeable fashion during coitus" (Jocelyn and Setchell, 1972). Although de Graaf's notion of homology of the female paraurethral glands and ducts as the female prostate with the male prostate was essentially but an intuitive idea, he is doubtless the discoverer of the female prostate and should be accepted and acknowledged as such.

    Some 200 years after de Graaf, the American gynecologist, Alexander J.C. Skene (1838-1900), redescribed the female prostate as being comprised of two main paraurethral ducts that bear his name - Skene's glands - opening on both sides of the urethral orifice (Skene, 1880). Following Skene's description, the origin, and even the presence and function of these (para)urethral ducts and glands, became the subject of considerable debate. This contributed to a general